NCT04147247View on ClinicalTrials.gov

A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread

PHASE1CompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

December 23, 2019

Primary Completion Date

May 6, 2021

Study Completion Date

May 27, 2021

Conditions
Neoplasms
Interventions
DRUG

BI 905681

Infusion

Trial Locations (3)

19107

Thomas Jefferson University, Philadelphia

34232

Florida Cancer Specialists, Sarasota

37203

Tennessee Oncology, PLLC, Nashville

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT04147247 - A Trial to Find the Safe Dose for BI 905681 in Patients With Incurable Tumours or Tumours That Have Spread | Biotech Hunter | Biotech Hunter